People who are prescribed opioid painkillers after receiving a heart pacemaker or defibrillator may be at risk for opioid abuse — and the higher the initial dose, the greater the risk, according to a new study. “The significance of this study is to make other electrophysiologists aware that even a low-risk procedure like a pacemaker…  read on >  read on >

A U.S. Food and Drug Administration advisory panel on Tuesday voted narrowly to recommend emergency use of Merck’s new antiviral pill to help prevent severe COVID-19 in high-risk patients. By a 13-10 count, the panelists recommended molnupiravir for use by older COVID-19 patients or those who have medical conditions that make them especially susceptible to…  read on >  read on >

Several Old Spice and Secret aerosol spray antiperspirants and hygiene products have been voluntarily recalled in the United States due to the presence of the cancer-causing chemical benzene, Proctor & Gamble says. Benzene exposure can occur by inhalation, orally and through the skin. It can lead to cancers including leukemia and blood cancer of the…  read on >

Coffee lovers know a steaming cup of java can quickly deliver energy and mental clarity every morning, but new research suggests it may also guard against Alzheimer’s disease in the long run. “Worldwide, a high proportion of adults drink coffee every day, making it one of the most popular beverages consumed,” said lead researcher Samantha…  read on >  read on >

Worried about climate change? You can do something about it every time you lift your fork, a new study suggests. Folks can reduce their personal carbon footprint by eating less red meat, nibbling fewer sweets and cutting back on tea, coffee and booze, according to the findings. “We all want to do our bit to…  read on >  read on >

Merck’s experimental COVID-19 antiviral pill appears effective, but may pose risks for pregnant women, including birth defects and toxicity to developing fetuses, according to the U.S. Food and Drug Administration. On Friday morning Merck announced updated results from its molnupiravir study that showed a smaller benefit than first thought: Among more than 1,400 adults in…  read on >  read on >